These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20347169)

  • 1. Stereotactic fractionated radiotherapy for Klatskin tumours.
    Momm F; Schubert E; Henne K; Hodapp N; Frommhold H; Harder J; Grosu AL; Becker G
    Radiother Oncol; 2010 Apr; 95(1):99-102. PubMed ID: 20347169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
    Schleicher UM; Staatz G; Alzen G; Andreopoulos D
    Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pre- and postoperative irradiation in the treatment of resectable Klatskin tumours].
    van Gulik TM; Rauws EA; González González D; Smits NJ; Bosma A; Gouma DJ
    Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1331-7. PubMed ID: 9380186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and surgical features of Klatskin tumors.
    Santoro E; Sacchi M; Carboni F; Santoro R; Scardamaglia F
    Chir Ital; 1999; 51(1):1-7. PubMed ID: 10514910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage.
    Born P; Rösch T; Brühl K; Sandschin W; Weigert N; Ott R; Frimberger E; Allescher HD; Hoffmann W; Neuhaus H; Classen M
    Z Gastroenterol; 2000 Jun; 38(6):483-9. PubMed ID: 10923359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour].
    Robles R; Parrilla P; Ramírez P; Sánchez-Bueno F; Marín C; Pastor P; Pons JA; Acosta F; Pérez-Flores D; De La Peña Morales J
    Cir Esp; 2010 Feb; 87(2):82-8. PubMed ID: 20074713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for survival in patients with inoperable Klatskin tumors.
    Arvanitakis M; Van Laethem JL; Pouzere S; Le Moine O; Deviere J
    Hepatogastroenterology; 2006; 53(67):21-7. PubMed ID: 16506370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original article: New surgical approaches to the Klatskin tumour.
    Van Gulik TM; Dinant S; Busch OR; Rauws EA; Obertop H; Gouma DJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():127-32. PubMed ID: 18081656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of orthotopic liver transplantation in the treatment of Klatskin tumor].
    Liang TB; Zheng SS; Shi QF; Wang WL; Shen Y; Zhang M; Yu J; Chen WB
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):972-5. PubMed ID: 16194350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-continuity hepatic resection for advanced hilar cholangiocarcinoma.
    Zervos EE; Pearson H; Durkin AJ; Thometz D; Rosemurgy P; Kelley S; Rosemurgy AS
    Am J Surg; 2004 Nov; 188(5):584-8. PubMed ID: 15546575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klatskin tumor--results of surgical therapy.
    Zovak M; Doko M; Glavan E; Hochstädter H; Roić G; Ljubicić N
    Coll Antropol; 2004 Jun; 28(1):317-23. PubMed ID: 15636089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies in hilar bile duct carcinoma (Klatskin's tumor)].
    Lammert F; Busch N; Nguyen HN; Matern S
    Dtsch Med Wochenschr; 1998 Oct; 123(40):1179-82. PubMed ID: 9793533
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of minimally invasive interventions in the treatment of complications caused by recidive Klatskin tumors].
    Lukovich P; Kupcsulik P; Winternitz T; Doros A; Illyés G
    Orv Hetil; 2003 Nov; 144(47):2311-4. PubMed ID: 14725049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
    Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
    Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of hilar cholangiocarcinoma (Klatskin tumor)--analysis of the curative strategies.
    Jaeck D; Bachellier P; Oussoultzoglou E; Weber JC; Wolf P
    Med Sci Monit; 2001 May; 7 Suppl 1():64-6. PubMed ID: 12211752
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence.
    Iachino C; Catsicojannis N; Dallera F
    J Exp Clin Cancer Res; 1998 Dec; 17(4):425-30. PubMed ID: 10089062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klatskin tumor--palliative therapy: the jury is still out or may be not yet in...
    Geller A
    Gastrointest Endosc; 2009 Jan; 69(1):63-5. PubMed ID: 19111687
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
    Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic liver transplantation for patients with Klatskin tumor.
    Zheng SS; Shi QF; Liang TB; Wu J; Wang WL; Shen Y; Zhang M
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):28-31. PubMed ID: 15730914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of surgery for Klatskin tumors.
    Lillemoe KD
    Curr Opin Gen Surg; 1994; ():161-7. PubMed ID: 7583956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.